Abstract
Peripheral blood progenitor cells (PBPCs) have been used with increasing frequency for autografting following high-dose chemotherapy [1]. Successful transplantation of PBPCs with complete and sustained engraftment has been shown in a variety of disorders, including ANLL, lymphoma, neuroblastoma, breast cancer, and other solid tumors [1–8]. When compared with autologous bone marrow transplantation, the advantages of this modality include a more rapid restoration of neutrophils and platelets, the possibility of autografting when bone marrow aspiration is hampered by tumor cell infiltration, fibrosis or hypoplasia following radio-/chemotherapy, and the possibility of reduced contamination with malignant cells in disseminated cancer [9]. The actual level of malignant cell contamination, however, is a matter of debate [10] as well as the exact number of mononuclear cells, CFU-GM colonies or CD34+ cells which have to be transplanted in order to allow a complete and sustained hematopoietic reconstitution [11, 12].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kessinger A, Armitage JO (1991) The evolving role of autologous peripheral stem cell transplantation following high-dose chemotherapy for malignancies. Blood 77: 211–213
Körbling M, Holle R, Haas R, Knauf W, Dörken B, Ho AD, Kuse R, Pralle H, Fliedner TM, Hunstein W (1990) Autologous blood stem-cell transplantation in patients with advanced Hodgkin’s disease and prior radiation to the pelvic site. J Clin Oncol 8: 978–985
Kessinger A, Armitage JO, Smith DM, Landmark JD, Bierman PJ, Weisenburger DD (1989) High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74: 1260–1266
Körbling M, Dörken B, Ho AD et al (1986) Autologous transplantation of blood-derived hematopoietic stem cells after myeloablative therapy in a patient with Bur-kitt’s lymphoma. Blood 72: 529–532
Juttner CA, To LB, Ho JQK et al (1988) Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 20: 40
Sheridan WP, Begley CG, Juttner C, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet i: 640
Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gondola L, Stern AC, Landsdorp PM, Bonadonna G, Gianni AM (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400–406
Elias AD, Ayash L, Anderson C, Hund M, Wheller C, Schwartz G, Telpler I, Mazanet R, Lynch C, Pap S, Pelaez J, Reich E, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Frei E, Antman H (1992) Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification in breast cancer. Blood 79: 3036–3042
To LB, Russel J, Moore S, Juttner CA (1987) Residual leukemia cannot be detected in very early remission peripheral blood stem cell collections in acute non-lymphoblastic leukemia. Leuk Res 11: 327
Moss TJ, Sandes DG, Lasky LC, Bostrom B (1990) Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 75: 1879–1883
Lasky LC, Ash RC, Kersey JH, Zanjani ED, McCullough J (1982) Collection of pluripotential hematopoietic stem cells by cytapheresis. Blood 59: 822
Juttner CA, To LB, Haylock DN, Cyson PG, Thorp D, Dart GW, Ho JQK, Horvath N, Bardy P (1989) Autologous blood stem cell transplantation. Transplant Proc 21: 2929
Richman CM, Weiner RS, Yankee RA (1976) Increase in circulating stem cells following chemotherapy in man. Blood 47: 1031
Abrams RA, McCormack, Bowles C, Deisseroth AB (1981) Cyclophosphamide treatment expands the circulating haemopoietic stem cell pool in dogs. J Clin Invest 67: 1392
To LB, Shepperd M, Haylock DN, Dyson PG, Charles P, Thorp L, Dale BM, Dart GW, Roberts MM, Sage RE (1989) Single high doses of cyclophosphamide enable the collection of high numbers of haemopoietic stem cells from the peripheral blood. Exp Hematol 18: 442
Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W (1990) Successful autologous transplantation of blood stem cells mobilized with rhGM-CSF. Exp Hematol 18: 94
Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD (1988) GM-CSF expands the circulating haemopoietic progenitor cell compartment in man. Lancet ii: 1194–1200
Villeval JL, Dührsen U, Morstyn G, Metcalf D (1990) Effect of recombinant human GM-CSF on progenitor cells in patients with advanced malignancies. Br J Hematol 74: 36
Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D (1988) Effects of recombinant human G-CSF on hematopoietic progenitor cells in cancer patients. Blood 72: 2074
Pettengell R, Demuynck H, Testa NG, Dexter TM (1992) The engraftment capacity of peripheral blood progenitor cells mobilized with chemotherapy ± G-CSF. Int J Cell Clon 10: 59–61
Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet ii: 580–585
Kanz L, Brugger W, Bross KJ, Frisch J, Schulz G, Mertelsmann R (1991) IL-3+ GM-CSF induced mobilization of myeloid, erythroid, multilineage as well as megakaryocytic progenitor cells following polychemotherapy in cancer patients. Blood 78: 1222 (abstr)
Brugger W, Bross J, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L (1992) Mobilization of PBPCs by sequential administration of IL-3 and GM-CSF following poly-chemotherapy with etoposide, Ifosfamide and Cisplatin. Blood 79: 1193–1200
Kanz L, Brugger W, Bross J, Mertelsmann R (1992) Correlation analyses between CD34+ cells and clonogenic progenitors mobilized into the peripheral blood by IL-3+ GM-CSF following polychemotherapy in cancer patients. Int J Cell Cloning 10: 68–70
Brugger W, Frisch J, Schulz G, Mertelsmann R, Kanz L (1992) Sequential administration of IL-3 and GM-CSF following standard-dose combination chemotherapy with Etoposide, Ifosfamide and Cisplatin. J Clin Oncol 10: 1193–1200
Brugger W, Birken R, Bertz H, Hecht T, Pressler, Frisch J, Schulz G, Mertelsmann R, Kanz L (1993) Peripheral blood progenitor cells mobilized by chemotherapy plus G-CSF accelerate both neutrophil and platelet recovery after high-dose VP16, Ifosfamide, and Cisplatin. Br J Hematol (in press)
Brugger W, Möcklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L (1993) Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1/3, lnterleukin-6, Interleukin-3, Interferon-gamma, and Erythropoietin. Blood (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag France
About this paper
Cite this paper
Brugger, W., Mertelsmann, R., Kanz, L. (1994). Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_6
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0765-2_6
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0767-6
Online ISBN: 978-2-8178-0765-2
eBook Packages: Springer Book Archive